KR20030026939A - The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods - Google Patents
The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods Download PDFInfo
- Publication number
- KR20030026939A KR20030026939A KR1020030005387A KR20030005387A KR20030026939A KR 20030026939 A KR20030026939 A KR 20030026939A KR 1020030005387 A KR1020030005387 A KR 1020030005387A KR 20030005387 A KR20030005387 A KR 20030005387A KR 20030026939 A KR20030026939 A KR 20030026939A
- Authority
- KR
- South Korea
- Prior art keywords
- guava
- guava leaf
- leaf
- weight
- leaves
- Prior art date
Links
- 241000508269 Psidium Species 0.000 title claims abstract description 73
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 208000008589 Obesity Diseases 0.000 title claims abstract description 6
- 235000020824 obesity Nutrition 0.000 title claims abstract description 6
- 230000032683 aging Effects 0.000 title abstract 2
- 241001122767 Theaceae Species 0.000 title description 15
- 235000013376 functional food Nutrition 0.000 title 1
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 11
- 235000013402 health food Nutrition 0.000 claims abstract description 9
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 6
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 6
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 6
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 6
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 5
- 235000010654 Melissa officinalis Nutrition 0.000 claims abstract description 5
- 244000062730 Melissa officinalis Species 0.000 claims abstract description 5
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 5
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 4
- 235000013668 Aloysia triphylla Nutrition 0.000 claims abstract description 3
- 240000008554 Aloysia triphylla Species 0.000 claims abstract description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 3
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 3
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 3
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 3
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 3
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 3
- 239000001102 lavandula vera Substances 0.000 claims abstract description 3
- 235000018219 lavender Nutrition 0.000 claims abstract description 3
- 235000002020 sage Nutrition 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims abstract 6
- 244000269722 Thea sinensis Species 0.000 claims abstract 5
- 241000220225 Malus Species 0.000 claims abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 235000021329 brown rice Nutrition 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 239000002075 main ingredient Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 241000209020 Cornus Species 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- 244000187664 Nerium oleander Species 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 241000411851 herbal medicine Species 0.000 claims 1
- 235000019155 vitamin A Nutrition 0.000 claims 1
- 239000011719 vitamin A Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 5
- 239000008103 glucose Substances 0.000 abstract description 5
- 240000007594 Oryza sativa Species 0.000 abstract description 2
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 2
- 244000178231 Rosmarinus officinalis Species 0.000 abstract description 2
- 241001072909 Salvia Species 0.000 abstract description 2
- 235000017276 Salvia Nutrition 0.000 abstract description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 235000009566 rice Nutrition 0.000 abstract description 2
- 239000001585 thymus vulgaris Substances 0.000 abstract description 2
- 240000000249 Morus alba Species 0.000 abstract 2
- 235000008708 Morus alba Nutrition 0.000 abstract 2
- 241001625885 Polygonatum odoratum var. pluriflorum Species 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract 1
- 241001507943 Cormus Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 241000784222 Inula japonica Species 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 240000002657 Thymus vulgaris Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000004584 weight gain Effects 0.000 abstract 1
- 235000019786 weight gain Nutrition 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 230000008859 change Effects 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 150000002989 phenols Chemical class 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 235000009852 Cucurbita pepo Nutrition 0.000 description 3
- 240000001980 Cucurbita pepo Species 0.000 description 3
- 235000019606 astringent taste Nutrition 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical class C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- GMVPRGQOIOIIMI-DODZYUBVSA-N 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DODZYUBVSA-N 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000976924 Inca Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 244000182807 Mentha suaveolens Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 241000246358 Thymus Species 0.000 description 1
- 235000017715 Thymus pulegioides Nutrition 0.000 description 1
- 240000006001 Thymus serpyllum Species 0.000 description 1
- 235000004054 Thymus serpyllum Nutrition 0.000 description 1
- 241001672648 Vieira Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000002660 insulin-secreting cell Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 229940127209 oral hypoglycaemic agent Drugs 0.000 description 1
- 229940125395 oral insulin Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- -1 tannin Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/13—General methods of cooking foods, e.g. by roasting or frying using water or steam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 구아바잎을 주성분으로 하는 목적별대응차의 제조방법 및 건강식품에 관한 것으로, 보다 상세하게는 당뇨병치료효과, 비만개선효과, 노화방지효과를 가지고 있는 구아바잎을 주성분으로 하여, 구아바잎의 가공전처리를 통하여 총페놀함량을 높이고 독특한 맛은 유지하되 쓴맛이 적은 차의 제조방법 이를 이용한건강식품에 관한 것이다.The present invention relates to a manufacturing method and a health food for a purpose-matched tea having a guava leaf as a main component, and more specifically, a guava leaf having a diabetes treatment effect, an obesity improvement effect, and an anti-aging effect as a main component. To improve the total phenol content through the pre-processing and to maintain a distinctive taste, but less bitter taste tea relates to a health food using the same.
최근 산업사회의 발달과 식생활습관등의 변화로 고지방의 인스턴트식품 및 육류소비가 보편화 되면서, 인체내부에 지방 등이 형성되는 고지혈증, 동맥경화, 고혈압, 당뇨병 등과 같은 만성 성인병환자가 급증하고 있는 추세에 있다. 특히 당뇨병은 그의 합병증으로 암, 신장 및 순환기 질환, 동맥경화, 실명까지 유발하며, 이로 인해 전 세계적으로 높은 사망률을 나타내는 질환으로 현재에도 그 사망률이 지속적으로 증가하고 있다(Mann, J.I., The Lancet, 360: 783∼789, 2002). 당뇨병의 증상은 다양하지만 대표적으로 다음(多飮), 다뇨(多尿), 다식(多食)을 들 수 있는데, 혈압내에 높은 혈당치 때문에 소변으로 포도당 및 많은량의 수분이 삼투압에 의해서 배설되어 심한 갈증을 느끼거나 공복감으로 인해 음식을 많이 먹게 된다.Recently, with the development of industrial society and changes in dietary habits, high-fat fast food and meat consumption are becoming more common, and chronic adult patients such as hyperlipidemia, arteriosclerosis, high blood pressure, diabetes, etc., in which fat is formed in the human body are rapidly increasing. have. In particular, diabetes is a complication that causes cancer, kidney and circulatory diseases, arteriosclerosis, and blindness. As a result, the mortality rate continues to increase worldwide (Mann, JI, The Lancet, 360: 783-789, 2002). Symptoms of diabetes may vary, but typically include Daum, Polyuria, and Dasik. Because of the high blood sugar level in blood pressure, glucose and large amounts of water are excreted by osmotic pressure in urine. Thirst or hunger can cause you to eat a lot of food.
당뇨병은 크게 인슐린 의존형 당뇨병(제1형)과 인슐린 비의존형 당뇨병(제2형)으로 분류된다. 소아형당뇨병이라고도 불리는 제1형 당뇨병은 주로 유전적 환경적 원인에 의해 소아를 비롯한 젊은층에서 주로 발병되며, 췌장의 인슐린 분비세포인 베타세포가 파괴되어 심한 인슐린 결핍증상이 나타나며, 당뇨병성 산혈증과 같은 위독한 증상으로 발견되기도 한다. 성인형 당뇨병이라 불리는 제2형 당뇨병은 주로 40대 이상의 성인에게서 발병되며, 우리나라 당뇨환자의 대부분을 차지한다. 또한 췌장의 베타세포에서 인슐린의 생산이 부족하거나, 세포가 인슐린을 인식하지 못해 발병되기도 하며, 최근 경제성장과 함께 변화된 식습관으로 고지방, 고칼로리의 음식과 스트레스 및 운동부족 등이 주 요인으로 관여하고 있다. 우리나라 사람의 식이 구성 특성상 열량소 중에서 당질이 50∼70%로 가장 많고, 쌀밥을 주식으로하기 때문에 당질 중에서도 전분의 섭취량이 특히 많아지게 된다. 전분은 아밀라아제에 의해서 이당류나 삼당류로 분해 되고, 소장내의 알파글리코시다제에 의해 단당류인 포도당으로 분해 되어 흡수됨으로 혈당이 증가된다. 현재 혈당강하제로 설포닐우레아(sulfonylureas)제제, 비구아나이드(biguanides)계의 경구혈당강하제나 인슐린 주사 등의 국한적인 치료를 하고 있다. 최근에는 당뇨병의 치료를 위해 합성된 약물보다는 안전성 있는 천연물에서 약리효과가 있는 물질을 탐색하는 연구가 진행되고 있으며, 400여종의 야생식용식물들이 당뇨병 치료에 효과가 있다고 보고 되고 있으나(Bailey, C. J., Day, C., Diabetic Care, 12; 553∼564, 1989), 대부분 아직 그 약리효능이나 생리적 기전에 대해서는 입증되지 못하고 있는 실정이다. 그러나 많은 관심이 집중되고 있으며, 항산화 효과 및 혈당강하 효과에 대하여 다수의 연구논문들이 발표되고 있다.Diabetes is largely classified into insulin-dependent diabetes (type 1) and insulin-independent diabetes (type 2). Type 1 diabetes, also known as pediatric diabetes, is caused mainly by young people, including children, due to genetic and environmental causes, and causes severe insulin deficiency due to the destruction of beta cells, which are pancreatic insulin secreting cells, and diabetic acidosis. It is also found to be a serious condition. Type 2 diabetes, called adult type diabetes, occurs mainly in adults over 40 years of age, and accounts for most of the diabetic patients in Korea. In addition, the production of insulin in the pancreatic beta cells, or the lack of insulin recognition of the cells are caused by the recent economic growth and changes in eating habits, high-fat, high-calorie food and stress and lack of exercise are major factors have. Due to the dietary composition of Korean people, the sugar content is 50-70%, the highest in calories, and rice is a staple food, so the intake of starch is particularly high among sugars. Starch is decomposed into disaccharides or trisaccharides by amylase, and the blood glucose is increased by being broken down and absorbed into glucose, a monosaccharide by alphaglycosidase in the small intestine. Currently, the drug is limited to sulfonylureas, biguanides, oral hypoglycemic agents, and insulin injections. Recently, research has been conducted to search for substances with pharmacological effects from safe natural products rather than drugs synthesized for the treatment of diabetes mellitus, and 400 kinds of wild edible plants have been reported to be effective in treating diabetes (Bailey, CJ, Day, C., Diabetic Care, 12; 553-564, 1989), most of which have not yet been demonstrated for their pharmacological efficacy or physiological mechanisms. However, much attention has been focused, and a number of research papers have been published on antioxidant and hypoglycemic effects.
최근 건강식품의 관심대상이 되고 있는 구아바는 포도과에 속하는 열대식물로서 중앙아메리카의 고산지대가 원산지로 옛 잉카인들이 고산지대에서 재배하고 즐겨 먹었으며, 화분식물은 물론 잎, 나무껍질, 열매 등을 건강식 및 약용으로 이용하였다. 특히 구아바는 아시아 및 아프리카 지역에서는 비타민 C의 부족으로 일어나는 병리괴혈병을 예방 및 치료하기위해 사용하고 있으며(Watt, J.M., E & S Livingstone, London, PP. 789∼799), 구아바잎은 설사 및 소화기계장애를 일으키는 식중독균에 대해서도 강한 항균력을 가지고 있다(Vieira, R.H.S.F., et al., Rev. Inst. Med. trop. S. Paulo, 43; 145∼148, 2001). 이외에도, 볼리비아, 이집트, 인도 및 중국에서는 구아바잎이 감기와 폐결핵을 치료 및 항염증과 지혈제로서사용하였으며, 멕시코에서는 활성 성분으로 생각되어지는 quercetin과 이의 배당체 성분들이 설사를 멈추게 한다고 연구되어졌다. 또한, 쥐 및 사람을 통한 임상실험에서도 혈당을 강하하는 효과가 있다고 다수 보고되고 있으며(Deguchi, Y., et al., Nippon Nogeikagaku Kaishi, 72: 923∼931, 1998), 일본에서는 구아바잎에 있는 탄닌 성분들이 세포의 신진대사를 활발하게 하여 췌장기능을 개선시켜 인슐린 분비촉진과 인슐린의 기능 향상에 대한 효과와 뿐만 아니라, 구아바잎 추출물은 1 mg/ml 의 농도에서 아밀라아제(amylase)의 활성을 완전히 억제하는 것으로 나타났으며, 당뇨병쥐를 통한 invitro실험에서도 혈당강하 효과를 보였다고 보고 되었으며(たかした, ぃのうえ, 食品と開發, 33, (9); 42-44), 이외에도 아토피성피부염치료 및 미백효과도 있는 것으로 알려져 있다. 구아바잎의 성분에 대한 연구로는 sesquiterpene, triterpenoid, flavonoid, coumarin, alkaloid, tannin등이 있는 것으로 보고되고 있다.Guava, which has recently been the subject of interest in health foods, is a tropical plant belonging to the family of grapes, originated from the alpine region of Central America, and the former Inca people cultivated and enjoyed it in the alpine region, and enjoyed not only pollen plants but also leaves, bark and berries. It was used for medicinal purposes. In particular, guava is used to prevent and treat pathological scurvy caused by vitamin C deficiency in Asia and Africa (Watt, JM, E & S Livingstone, London, pp. 789-799). It has strong antibacterial activity against food poisoning bacteria that cause mechanical disorders (Vieira, RHSF, et al., Rev. Inst. Med. Trop. S. Paulo, 43; 145-148, 2001). In addition, in Bolivia, Egypt, India, and China, guava leaves have been used to treat colds and tuberculosis as treatments, anti-inflammatory and hemostatic agents, and quercetin and its glycosides, which are considered active in Mexico, have been studied to stop diarrhea. In addition, a number of clinical trials in rats and humans have been reported to have a hypoglycemic effect (Deguchi, Y., et al., Nippon Nogeikagaku Kaishi, 72: 923-931, 1998). Tannins enhance the metabolism of cells, improve pancreatic function, and promote insulin secretion and insulin function. In addition, guava leaf extracts completely inhibit amylase activity at a concentration of 1 mg / ml. It has been reported to suppress the blood glucose level in the invitro experiments of diabetic rats (Takashita, ぃ の う え, 食品 と 開發, 33, (9); 42-44), and in addition to the treatment of atopic dermatitis It is also known to have a whitening effect. Studies on the composition of guava leaves have been reported to include sesquiterpene, triterpenoid, flavonoid, coumarin, alkaloid, and tannin.
우리나라에서는 1991년부터 본격적으로 재배법이 연구되어 제주도 및 경기도 일대에서 토착화에 성공하였지만, 관상용으로 이용하거나, 열매만 소비되고 있는 실정이다.In Korea, the cultivation method was studied in earnest from 1991, and it succeeded indigenization in Jeju and Gyeonggi-do areas, but it is used for ornamental purposes or only fruit is consumed.
따라서 본 발명의 목적은 구아바잎 또는 열매를 주원료로 사용하여 폴리페놀, 비타민 C, 철분 등 영양소가 풍부한 혈당강하 및 피부미용효과가 월등한 건강차를 제공함에 있다.Accordingly, an object of the present invention is to provide a healthy tea having excellent blood sugar lowering effect and skin beauty effect rich in nutrients such as polyphenol, vitamin C, and iron by using guava leaf or fruit as a main ingredient.
본 발명의 다른 목적은 상기 구아바잎 또는 열매를 주원료로 사용하여 혈당강하 및 피부미용효과가 월등한 캡슐, 정제(타블렛), 엑기스, 및 건강식품을 제공함에 있다.Another object of the present invention is to provide a capsule, tablets (tablets), extracts, and health foods having excellent blood sugar lowering and skin beauty effects using the guava leaf or fruit as a main ingredient.
따라서, 본 발명에서 이루고자 하는 기술적 과제는 구아바잎 또는 열매를 주원료로 사용하되 항암 및 혈당강하 작용이 있는 상엽 및 둥굴레를 포함하여 기능을 보강하고, 노화방지효과와 간장보호효과가 있는 영지를 포함하며, 향과 풍미를 위하여 페퍼민트, 레몬밤, 현미 등을 혼합하여 부원료로 하는 것을 특징으로 하며, 현대성인병을 예방하여 건강증진에 기여할 수 있는 차, 액상차, 음료, 과립, 정제 등과 같은 기능성 건강식품을 제공하는 것을 목적으로 한다.Therefore, the technical problem to be achieved in the present invention is to use guava leaf or fruit as the main raw material, including the upper lobe and the round oleum having anti-cancer and hypoglycemic action, and reinforces the function, including the ganoderma lucidum having anti-aging effect and liver protection effect Characterized by mixing peppermint, lemon balm, brown rice, etc. for flavor and flavor, and functional health foods such as tea, liquid tea, beverages, granules, and tablets that can contribute to health promotion by preventing modern adult diseases. The purpose is to provide.
이하 본 발명의 구성 및 작용을 상세히 설명한다.Hereinafter, the configuration and operation of the present invention will be described in detail.
도 1은 전처리 조건에 따른 총페놀성 화합물 함량의 변화 그래프1 is a graph of the change in total phenolic compound content according to pretreatment conditions
(구아바잎 5 g를 증류수 100 ml로 추출하였을 때 추출용액 100 ml에 들어있는 총페놀성화합물 함량)(Total phenolic compound content in 100 ml of extract solution when 5 g of guava leaf is extracted with 100 ml of distilled water)
도 2는 전처리 조건에 따른 전자공여능의 변화 그래프2 is a graph of the change of electron donating ability according to pretreatment conditions
(구아바잎 5g를 증류수 100ml로 추출하였을 때 추출용액 0.1ml를 사용한 전자공여능)(Electrodonating ability using 0.1 ml of extraction solution when 5 g of guava leaf was extracted with 100 ml of distilled water)
본 발명은 주성분인 구아바잎의 전처리 조건에 따른 이화학적 특성을 분석하는 단계와; 건조조건에 따른 영향을 분석하는 단계와; 티백차의 제조단계와; 캡슐 및 타블렛의 제조방법으로 구성되어있다.The present invention comprises the steps of analyzing the physicochemical characteristics according to the pretreatment conditions of the guava leaf is the main component; Analyzing the effect of drying conditions; Manufacturing a tea bag; Consists of manufacturing capsules and tablets.
구아바는 잎 또는 열매가 주로 사용되는데, 생잎과 건조잎의 성분변화와 열매의 성분을 비교하여 보면, 생잎은 열매에서보다 더 많은 비타민C를 포함하고 있으며, 생잎 및 건조잎에서 총페놀함량도 열매보다 약 200배 많은 양을 보였다. 기타 이화학적인 비교특성을 표 1에 나타내었다.Guava is mainly used for leaves or fruits. Comparing the composition of fresh and dried leaves and the composition of the fruit, the raw leaves contain more vitamin C than in the fruit, and the total phenol content in the fresh and dried leaves is also fruit. It was about 200 times larger than that. Other physical and chemical properties are shown in Table 1.
하기 표 1의 결과에서 알 수 있는 바와 같이, 생잎이 비타민C와 총페놀함량에서 비교적 많은 함유량을 보였으나, 구아바잎의 혈당강하를 비롯한 주된 생리활성을 폴리페놀이 가지고 있으므로, 혈당강하효과, 비만개선효과, 노화방지효과를위한 제품으로 열매보다 생잎을 사용하는 것이 바람직하며, 보다 바람직하게는 폴리페놀함량이 가장 많은 건조잎을 사용하는 것이다.As can be seen from the results of Table 1, the raw leaves showed a relatively high content in vitamin C and total phenolic content, but since the polyphenols have the main physiological activity including the hypoglycemic effect of guava leaf, hypoglycemic effect, obesity As a product for improving effect and anti-aging effect, it is preferable to use raw leaves rather than fruits, and more preferably to use dried leaves having the highest polyphenol content.
이하 실시예를 통하여 본 발명을 상세하게 설명한다. 그러나 다음 실시예들은 본 발명을 예시하는 것으로 본 발명의 범위를 한정하는 것은 아니다.The present invention will be described in detail through the following examples. However, the following examples are illustrative of the invention and do not limit the scope of the invention.
(실시예 1): 구아바잎의 전처리 조건에 따른 이화학적 특성(Example 1): Physicochemical Properties According to Pretreatment Conditions of Guava Leaf
구아바잎을 그대로 건조, 볶음처리, 증숙 및 발효 후 건조하여 관능검사를 하였을 때 그대로 건조 및 볶음처리를 한 구아바잎의 경우 강한 떫은맛과 풋내를 나타내는 것으로 나타났으며 반면에 증자 또는 발효처리를 할 경우 관능적 품질이 다른 처리구에 비하여 좋은 것으로 나타났다. 따라서 발효시 온도를 40, 50, 60, 70℃에서 12, 24, 36, 48 hr 처리를 했을 때의 이화학적 특성변화, 열처리에서 데치기 시간 30 sec, 1 min, 3 min, 5 min 처리시 이화학적 특성변화 및 증자시간을30 sec, 1 min, 3 min, 5 min으로 하였을 때의 이화학적 특성변화를 알아보았다.When guava leaves were dried, roasted, steamed and fermented, and dried and roasted, the guava leaf, which had been dried and roasted, showed strong astringent taste and freshness. Sensory quality was found to be better than other treatments. Therefore, the change of physicochemical properties when 12, 24, 36, 48 hr was treated at 40, 50, 60, 70 ° C during fermentation, and decay time at 30 sec, 1 min, 3 min, 5 min Changes in physicochemical properties when the chemical properties and the steaming time were set to 30 sec, 1 min, 3 min, and 5 min were investigated.
① 총페놀성 화합물 함량의 변화① Change of total phenolic compound content
구아바잎의 전처리 온도 및 시간에 따른 총페놀성 화합물 함량 변화는 도 1과 같다. 즉, 발효 잎의 경우 온도가 높아지고 시간이 길어질수록 감소하였다. 이는 발효가 진행되는 동안 온도가 높아지고 시간이 길어짐에 따라 구아바잎의 탄닌 등의 페놀성 물질들이 불용화 되어 감소되어졌다고 사료된다. 데친 잎의 경우 시간이 경과할수록 약간 감소하였으나, 증자 잎의 경우 시간의 경과에 따라 차이가 없었다.The total phenolic compound content change with the pretreatment temperature and time of guava leaf is shown in FIG. In other words, in the case of fermented leaves, the temperature increased and the length decreased. It is thought that phenolic substances such as tannins of guava leaf were insoluble and decreased as the temperature increased and time increased during fermentation. Poached leaves were slightly decreased with time, but there was no difference in the case of steamed leaves with time.
② 전자공여능의 변화② Change of electron donating ability
인체에 유익한 천연 항산화제에 관한 연구는 오래 전부터 진행되어 왔으며 대부분의 천연 항산화제는 식물기원의 물질로서 주로 polyphenolic 물질로 알려져 있다. 식물의 polyphenolics의 항산화제 역할 중 free radical scavenger의 기능은 주로 electron donor로써의 역할이 중요시 되고 있다. 구아바잎의 전자공여능에서는 도 2에서와 같이 발효 잎의 경우 발효온도가 높을수록 높게 나타났으며, 40℃와 50℃에서는 시간이 길어질수록 증가하였나. 60℃ 및 70℃에서는 시간이 길어질수록 감소하는 경향이었다. 데친 잎 및 증자 잎의 경우 전자공여능에 있어서 90% 이상으로 높게 나타났다. 이러한 현상은 앞에서 설명한 총페놀성 물질의 경향과 유사한 것으로 구아바잎의 페놀성 물질이 전자공여능에 영향을 미친다는 것을 알 수 있었다.Studies on natural antioxidants that are beneficial to humans have been conducted for a long time, and most natural antioxidants are plant-based substances, mainly known as polyphenolic substances. The role of free radical scavenger among the polyphenolics antioxidants in plants is mainly considered as the electron donor. In the electron donating ability of the guava leaf, as shown in Figure 2 fermented leaf was higher as the fermentation temperature was higher, was increased as time increases at 40 ℃ and 50 ℃. At 60 ° C. and 70 ° C., there was a tendency to decrease with longer time. Poached and steamed leaves were higher than 90% in electron donating ability. This phenomenon is similar to the tendency of the total phenolic substances described above, it can be seen that the phenolic substance of guava leaf affects the electron donating ability.
③ 관능적 품질의 변화③ change in sensory quality
앞서 행한 이화학적 품질특성 평가에서 60℃, 12 시간 발효처리잎과 무처리건조잎, 1분 데침 후 건조잎, 1분 증숙 후 건조잎의 품질특성를 알아보기 위하여 5점 채점법으로 관능검사한 결과를 표 2에 나타냈다.In the evaluation of physicochemical properties, the results of sensory evaluation by five-point scoring method were examined to determine the quality characteristics of 60 ° C, 12-hour fermented leaves and untreated dried leaves, dried leaves after 1-minute decay, and dried leaves after 1-minute steaming. Table 2 shows.
데침 및 증숙 후 건조한 잎이 발효처리 후 건조한 잎에 비하여 전반적으로 높게 나타났으나 떫은맛으로 인하여 평점이 낮게 나타났다. 향에 있어서는 데침(1 min) 및 증자(1 min) 처리가 좀 더 우수한 것으로 나타났다. 따라서 구아바잎의 전처리 조건으로 데침 처리를 1분정도 하는 것이 바람직하다.After drying and steaming, the dried leaves were generally higher than the dried leaves after fermentation, but the score was low due to the astringent taste. In terms of fragrance, the treatment of 1 min and 1 min was better. Therefore, the pretreatment condition of guava leaf is preferably carried out for about 1 minute.
(실시예 2): 건조조건에 따른 영향Example 2 Influence by Drying Conditions
데치기 후 건조 온도를 50℃ 및 60℃에서 건조하여 티백을 제조한 후 1개 티백(1.5g) 에 90℃ 물 100 ml를 부어 1분간 추출하여 가용성 고형분 함량 및 총페놀성 화합물 함량을 측정하였다. 그 결과를 표 3에 나타내었다. 가용성 고형분 함량에서는 60℃에서 건조한 것이 더 높게 나타났으며, 총페놀성 화합물 함량에 있어서는 두 구간이 유사하게 나타났다. 그 결과로 60℃에서 건조를 하더라도 구아바잎의 총페놀성 화합물 함량에서는 큰 변화가 없는 것으로 나타났다.After poking, the drying temperature was dried at 50 ° C. and 60 ° C. to prepare a tea bag, and then 100 ml of 90 ° C. water was poured into one tea bag (1.5 g), followed by extraction for 1 minute to measure the soluble solids content and the total phenolic compound content. The results are shown in Table 3. Drying at 60 ° C was higher for soluble solids content, and the two sections were similar for total phenolic compound content. As a result, there was no significant change in the total phenolic compound content of guava leaf even if dried at 60 ℃.
(실시예 2): 구아바잎 티백차의 제조Example 2 Preparation of Guava Leaf Tea Bag Tea
① 허브첨가에 따른 티백차의 관능검사① Sensory test of tea bag tea by adding herbs
구아바잎을 허브와 혼합하여 티백차를 제조하고 관능평가를 실시하였고 그 결과를 표 4에 나타냈다.Guava leaf was mixed with herbs to prepare teabag tea, and sensory evaluation was performed. The results are shown in Table 4.
본 발명에 따른 허브조성물에 있어 레몬밤, 페퍼민트, 타임, 로즈마리, 애플민트 및 라벤더, 세이지, 티트리, 레몬타임, 레몬버베나 그룹에서 선택된 하나 또는 그 이상의 허브식물을 첨가 할 수 있다.In the herbal composition according to the present invention, one or more herbal plants selected from lemon balm, peppermint, thyme, rosemary, applemint and lavender, sage, tea tree, lemon thyme and lemon verbena can be added.
<배합조건><Mixing conditions>
시료1: 구아바잎 100.0 중량%Sample 1: 100.0 wt% guava leaf
시료2: 구아바잎 90.0중량% + 레몬밤 10.0 중량%Sample 2: 90.0 wt% guava leaf + 10.0 wt% lemon balm
시료3: 구아바잎 90.0 중량% + 페퍼민트 10.0 중량%Sample 3: Guava Leaf 90.0 wt% + Peppermint 10.0 wt%
시료4: 구아바잎 80.0 중량% + 레몬밤 10.0 중량% + 페퍼민트 10.0 중량%Sample 4: Guava Leaf 80.0 wt% + Lemon Balm 10.0 wt% + Peppermint 10.0 wt%
② 둥굴레와 현미 첨가에 따른 구아바잎 티백차의 관능검사② Sensory Evaluation of Guava Leaf Tea Bag Tea with Addition of Brown Rice and Brown Rice
전반적으로 30대 이상의 경우 구수한 맛을 선호하는 경향이 있으므로 구수한 맛을 내기 위하여 당뇨에 효과가 좋은 것으로 알려져 있는 둥굴레와 볶음현미를 첨가하여 티백차를 제조 하였으며, 그 결과를 표 5에 나타냈다.In general, the thirties and older people tend to prefer the delicious taste, so the tea bag tea was prepared by the addition of round gourd and stir-fried brown rice, which are known to be effective for diabetes in order to produce the delicious taste, and the results are shown in Table 5.
<배합조건><Mixing conditions>
시료1: 구아바잎 100.0 중량%Sample 1: 100.0 wt% guava leaf
시료2: 구아바잎 60.0 중량% + 둥굴레 30.0 중량%Sample 2: Guava leaf 60.0% by weight + Dongle 30.0% by weight
시료3: 구아바잎 60.0 중량% + 현미 30.0 중량%Sample 3: Guava Leaf 60.0 wt% + Brown Rice 30.0 wt%
시료3: 구아바잎 60.0 중량% + 산수유 30.0 중량%Sample 3: Guava Leaf 60.0 wt% + Cornus 30.0 wt%
시료3: 구아바잎 60.0 중량% + 단삼 30.0 중량%Sample 3: Guava leaf 60.0 wt% + Salvia 30.0 wt%
그 결과 색, 향, 맛 및 전반적인 기호도에 있어서 무첨가군보다 우수한 것으로 나타났다. 특히 둥굴레 첨가군에서 둥굴레의 구수한 맛으로 인해 전반적인 기호도가 우수한 것으로 나타났다.As a result, it was found to be superior to the no addition group in color, aroma, taste and overall acceptability. In particular, in the group added to the group, the overall taste was excellent due to the taste of the group.
③ 향미 향상 방향③ direction to improve flavor
현재까지 진행된 실험결과 허브나 둥굴레, 현미 등을 첨가시 허브의 경우 독특한 향과 맛은 있으나 타겟층의 기호에 맞지 않고 둥굴레, 현미는 구아바잎 단독 사용 시에 비해 향미가 우수하지 못하며 결정적으로 기존 둥굴레차, 현미녹차와 맛에서 차이가 없었다. 따라서 본 발명에 있어 당뇨에 효능이 있는 부 조성물로서 상엽, 영지, 산수유, 오미자, 단삼, 금불초, 숙지황, 홍삼, 녹용, 감초, 감잎, 구기자, 어성초, 맥문동, 황기, 갈근, 하수오, 옥수수 및 모과로 이루어진 군에서 선택되는 어느 하나 또는 이상을 사용하는 것이 바람직하며, 상기단계에서 산뜻한 맛을 가미하고 떫은맛을 감소하기 위해 산수유, 단삼, 홍화씨, 사과분말, 및 구아바 열매 로 이루어진 군에서 선택되는 어느 하나 또는 이상을 사용하는 것이 바람직하다.As a result of the experiments conducted to date, when adding herbs, round gourd, brown rice, etc., herbs have unique flavor and taste, but do not fit the taste of target layer, but round gourd and brown rice do not have better flavor than guava leaf alone. There was no difference in taste with brown rice. Therefore, in the present invention as an auxiliary composition effective in diabetes, lettuce, Ganoderma lucidum, cornus, Schisandra chinensis, Dansam, Geumbulcho, Sukjiwang, Red ginseng, Deer antler, Licorice, Persimmon leaf, Gugija, Eoseongcho, Macmundong, Astragalus, Brown root, Sewao, Corn and Chinese quince It is preferable to use any one or more selected from the group consisting of, any one selected from the group consisting of cornus, sweet ginseng, safflower seed, apple powder, and guava fruit in order to add a fresh taste and reduce the astringent taste in the step. Or it is preferable to use the above.
(실시예 3): 구아바잎을 이용한 캡슐 제조Example 3 Preparation of Capsule Using Guava Leaf
건조된 구아바잎을 추출한 후 분무건조할 경우 색이 갈색으로 변하며, 또한 추출을 하고 여과를 하는 공정이 복잡하므로, 본 발명에서는 간편하고 구아바잎 전체를 이용할 수 있는 가수습식분쇄건조방식을 이용하여 구아바잎 분말 캡슐을 제조하였다.When the spray dried after the dried guava leaf is changed to a brown color, and the extraction and filtration process is complicated, in the present invention, the guava by using a hydrophilic pulverized drying method that can be easily used in the whole guava leaf Leaf powder capsules were prepared.
건조분말의 제조방법은 다음과 같다.The manufacturing method of the dry powder is as follows.
<구아바잎 가수습식분쇄건조><Guava Leaf Hydrolytic Crushing Drying>
① 투입액량: 5.835 kg, 생산량 : 490 g① Input liquid: 5.835 kg, Production volume: 490 g
② Dextrin 양: 원료 。Brix에 대한 추출 。Brix의 20% (584 g)② Dextrin amount: 20% (584 g) of raw material
Dextrin 양의 84%의 수율을 보임84% yield of Dextrin
③ Inlet temp.: 185℃③ Inlet temp .: 185 ℃
Out temp.: 89℃Out temp .: 89 ℃
Inverter meter: 53.6Inverter meter: 53.6
Speed: 20,000 rpmSpeed: 20,000 rpm
상기 건조물에 결합 및 붕해를 촉진하기 위하여 카복시메틸셀룰로스와 분말의 점착을 방지하기 위하여 스테아린산마르네슘을 첨가하여 캡슐을 제조하였다.A capsule was prepared by adding magnesium stearate to prevent adhesion between carboxymethyl cellulose and powder in order to promote binding and disintegration to the dry matter.
<배합비><Mixing ratio>
(실시예 4): 구아바잎 및 열매를 이용한 타블렛 제조Example 4 Preparation of Tablet Using Guava Leaf and Fruit
실시예 3에서와 같이 구아바잎 분말을 제조하였다. 구아바 열매는 가수습식 분무건조방법을 이용하여 미세한 분말을 하기와 같은 방법으로 제조하였다.Guava leaf powder was prepared as in Example 3. Guava fruit was prepared in the following manner by using a hydro-wet spray drying method.
<구아바 열매 가수습식분무건조><Guava fruit water spray drying>
① 투입액량: 2.5 kg, 제품생산량 : 340 g① Input liquid: 2.5 kg, Product output: 340 g
② 유당양: 원료 Brix에 대한 추출 Brix의 30% (356 g)② Lactose amount: 30% (356 g) of extract Brix to raw material Brix
유당양의 95% 수율을 보임.95% yield of lactose.
③ Inlet temp.: 185℃③ Inlet temp .: 185 ℃
Out temtp.: 89℃Out temtp .: 89 ℃
Inverter meter: 53.6Inverter meter: 53.6
Speed: 20,000 rpmSpeed: 20,000 rpm
습식분쇄기로 분쇄를 할 경우 씨가 갈려서 약간의 신맛이 나오므로 본 작업시 pulper로 씨 제거 후 사용하는 것이 바람직하며, 습식분쇄기로 분쇄후 Spray dry 작업을 하는 것이 바람직하다.When grinding with a wet grinder, the seeds are ground to give a little sour taste, so it is preferable to use it after removing the seeds with a pulper during this work, and spray dry after grinding with a wet grinder.
<타블렛 배합조건><Tablet mixing condition>
구아바잎 분말: 25.14∼40.0 중량%Guava Leaf Powder: 25.14-40.0 wt%
구아바열매 분말: 8.14∼23.0 중량%Guava Fruit Powder: 8.14 ~ 23.0 wt%
유당: 1.80 중량%Lactose: 1.80 wt%
CMC-Ca: 6.01중량%CMC-Ca: 6.01 wt%
스테아린산마그네슘: 4.21 중량%Magnesium stearate: 4.21 wt%
비타민 C: 2.17 중량%Vitamin C: 2.17 wt%
만니톨: 4.33 중량%Mannitol: 4.33 wt%
본 발명은 구아바잎의 주 약리 성분인 탄닌을 비롯한 폴리페놀을 다량 함유하여, 약리적 기능을 유지하면서 관능적인 기호성을 향상시켜 구아바잎차, 캡슐, 타블렛 등으로 개발함으로써 구아바를 손쉽게 접할 수 있게 함과 동시에 혈당강하를 통한 당뇨병 예방, 비만예방효과도 거둘 수 있다.The present invention contains a large amount of polyphenols including tannin, which is the main pharmacological component of guava leaf, and improves sensual palatability while maintaining the pharmacological function to make guava easily accessible by developing into guava leaf tea, capsules, tablets, etc. Diabetes prevention and obesity prevention effect can also be achieved by lowering blood sugar.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030005387A KR20030026939A (en) | 2003-01-27 | 2003-01-27 | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030005387A KR20030026939A (en) | 2003-01-27 | 2003-01-27 | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030026939A true KR20030026939A (en) | 2003-04-03 |
Family
ID=29578446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030005387A KR20030026939A (en) | 2003-01-27 | 2003-01-27 | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030026939A (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060084335A (en) * | 2005-01-19 | 2006-07-24 | 백흥관 | Method for preparing enzyme using guava |
US7247324B1 (en) | 2006-01-06 | 2007-07-24 | Amerilabtechnologies, Inc. | Method of using guava extract and composition including guava extract |
KR100836458B1 (en) * | 2006-10-31 | 2008-06-09 | 전규섭 | The method of the psidium guava functional food |
KR100879226B1 (en) * | 2008-07-08 | 2009-01-16 | 순천대학교 산학협력단 | A functional tea bag made by yacon and cereal |
KR100939976B1 (en) * | 2008-03-20 | 2010-02-03 | 백흥관 | Making method of guava leaf tee |
KR100941667B1 (en) * | 2007-12-03 | 2010-02-11 | 담양군 | Mixtured Tea of Gombo-Baechu Leaf Tea and Guava Leaf Tea |
KR101023134B1 (en) * | 2008-05-22 | 2011-03-25 | 송성건 | broth and method for manufacturing the broth |
EP2324718A1 (en) * | 2009-11-18 | 2011-05-25 | Young-Sam Jang | Health tea and method for preparing the same |
KR101049424B1 (en) * | 2008-12-19 | 2011-07-14 | 주식회사 빙그레 | Buckwheat draft drink and its manufacturing method |
US8313784B2 (en) | 2006-01-06 | 2012-11-20 | Amerilab Technologies, Inc. | Method of using guava extract |
KR101273946B1 (en) * | 2012-08-10 | 2013-06-12 | 김종진 | Method for content increase of polyphenol and lactic acid bacteria of apple by guava fermentation |
CN103549082A (en) * | 2013-10-29 | 2014-02-05 | 黄毅青 | Kidney-warming tea |
CN103549081A (en) * | 2013-10-29 | 2014-02-05 | 黄毅青 | Liver-protecting tea |
CN103704435A (en) * | 2013-12-18 | 2014-04-09 | 江阴天江药业有限公司 | Tea for dispelling effect of alcohol and protecting liver and preparation method thereof |
CN104273626A (en) * | 2014-10-20 | 2015-01-14 | 肥西县昌玖木本油料种植专业合作社 | Beverage containing inula japonica and preparation method thereof |
US9155773B2 (en) * | 2001-12-12 | 2015-10-13 | Angiolab, Inc. | Antiobesity composition |
KR20230079642A (en) * | 2021-11-29 | 2023-06-07 | 전윤희 | Manufacturing method of food and beverage containing garlic peel as an active ingredient |
-
2003
- 2003-01-27 KR KR1020030005387A patent/KR20030026939A/en not_active Application Discontinuation
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9155773B2 (en) * | 2001-12-12 | 2015-10-13 | Angiolab, Inc. | Antiobesity composition |
KR20060084335A (en) * | 2005-01-19 | 2006-07-24 | 백흥관 | Method for preparing enzyme using guava |
US8313784B2 (en) | 2006-01-06 | 2012-11-20 | Amerilab Technologies, Inc. | Method of using guava extract |
US7247324B1 (en) | 2006-01-06 | 2007-07-24 | Amerilabtechnologies, Inc. | Method of using guava extract and composition including guava extract |
US7611739B2 (en) | 2006-01-06 | 2009-11-03 | Amerilab Technologies, Inc. | Method of using guava extract and composition including guava extract |
KR100836458B1 (en) * | 2006-10-31 | 2008-06-09 | 전규섭 | The method of the psidium guava functional food |
KR100941667B1 (en) * | 2007-12-03 | 2010-02-11 | 담양군 | Mixtured Tea of Gombo-Baechu Leaf Tea and Guava Leaf Tea |
KR100939976B1 (en) * | 2008-03-20 | 2010-02-03 | 백흥관 | Making method of guava leaf tee |
KR101023134B1 (en) * | 2008-05-22 | 2011-03-25 | 송성건 | broth and method for manufacturing the broth |
KR100879226B1 (en) * | 2008-07-08 | 2009-01-16 | 순천대학교 산학협력단 | A functional tea bag made by yacon and cereal |
KR101049424B1 (en) * | 2008-12-19 | 2011-07-14 | 주식회사 빙그레 | Buckwheat draft drink and its manufacturing method |
EP2324718A1 (en) * | 2009-11-18 | 2011-05-25 | Young-Sam Jang | Health tea and method for preparing the same |
WO2014025169A1 (en) * | 2012-08-10 | 2014-02-13 | Kim Young Kum | Method for enhancing polyphenol and lactobacillus content of apples using fermented product of psidium guajava, and mixed concentrated solution of apples using said method |
KR101273946B1 (en) * | 2012-08-10 | 2013-06-12 | 김종진 | Method for content increase of polyphenol and lactic acid bacteria of apple by guava fermentation |
CN103549081A (en) * | 2013-10-29 | 2014-02-05 | 黄毅青 | Liver-protecting tea |
CN103549082A (en) * | 2013-10-29 | 2014-02-05 | 黄毅青 | Kidney-warming tea |
CN103549082B (en) * | 2013-10-29 | 2014-09-24 | 黄毅青 | Kidney-warming tea |
CN103549081B (en) * | 2013-10-29 | 2015-04-22 | 黄毅青 | Liver-protecting tea |
CN103704435A (en) * | 2013-12-18 | 2014-04-09 | 江阴天江药业有限公司 | Tea for dispelling effect of alcohol and protecting liver and preparation method thereof |
CN104273626A (en) * | 2014-10-20 | 2015-01-14 | 肥西县昌玖木本油料种植专业合作社 | Beverage containing inula japonica and preparation method thereof |
KR20230079642A (en) * | 2021-11-29 | 2023-06-07 | 전윤희 | Manufacturing method of food and beverage containing garlic peel as an active ingredient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20030026939A (en) | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods | |
KR101144059B1 (en) | Composition for prevention or treatment of diabete or obesity comprising Punica granatum extract and red ginseng extract | |
KR102257307B1 (en) | Method for preparing functional tea with bud of nipa fruticans wurmb and functional tea by the method | |
KR20200004942A (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR101140322B1 (en) | Composition of mixed herb medicine for leached tea | |
KR101166883B1 (en) | Composition of mixed herb medicine for leached tea | |
KR102243873B1 (en) | Fermented pills for reducing and preventing premature dementia and manufacturing methods thereof | |
KR101788253B1 (en) | Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic | |
KR20110080817A (en) | The healthy beverage manufactacturing method | |
KR101647917B1 (en) | Chestnut medicinal wine having extract of stachys sieboldii and methods for manufacturing thereof | |
CA2637349C (en) | Functional food composition for treating allergy, natural tea using the same and the manufacturing method thereof | |
KR102485016B1 (en) | Functional leached tea and manufacturing method of the same | |
CN105831318A (en) | Polypeptide tea for blood glucose reduction and manufacturing method of polypeptide tea | |
KR101162581B1 (en) | Dried Persimmon Having Good Functionality and Method for Preparing the Same | |
Lal et al. | Traditional, medicinal and nutraceutical values of minor fruit: Longan | |
CN108925807A (en) | A kind of solid beverage and preparation method thereof of hypoglycemic decompression | |
KR101953576B1 (en) | Functional beverage for anticancer and process for preparing the same | |
KR20100007569A (en) | A eatible cosmetic comprising edible snails, eel bones and oriental medicine ingredients for skin improment | |
KR20160082568A (en) | Composition comprising Rhus verniciflua for extraction and extraction mthod of the Composition | |
KR102485019B1 (en) | Functional leached tea and manufacturing method of the same | |
KR20200126839A (en) | Composition for relieving or improving hangover | |
US20070259058A1 (en) | Morinda herbal extracts and compositions thereof | |
Okafor et al. | Studies on the Effect of Processing Methods on the Antihyperglycemic activity of Herbal Teas from Leaves of Vernonia amygdalina Del | |
KR20040094961A (en) | Composition of herb tea powder, coffee powder, greentea powder for anti-obeseness and liquid thereof | |
KR102365198B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume, Polygonum multiflorum Thunberg and mountain ginseng |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |